Megasoft Ltd
Incorporated in 1999, Megasoft Ltd is
in the business of providing Telecom
services[1]
- Market Cap ₹ 568 Cr.
- Current Price ₹ 77.0
- High / Low ₹ 107 / 28.6
- Stock P/E
- Book Value ₹ 26.2
- Dividend Yield 0.00 %
- ROCE 7.72 %
- ROE 4.17 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.93 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -50.5% over past five years.
- Company has a low return on equity of 2.30% over last 3 years.
- Earnings include an other income of Rs.40.9 Cr.
- Working capital days have increased from 1,982 days to 6,396 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143.12 | 114.06 | 102.74 | 98.19 | 62.89 | 67.19 | 66.26 | 61.87 | 56.73 | 59.40 | 52.40 | 1.97 | 0.00 | |
109.11 | 92.58 | 80.21 | 73.43 | 47.33 | 61.57 | 56.65 | 59.90 | 51.35 | 55.29 | 70.72 | 19.67 | 10.46 | |
Operating Profit | 34.01 | 21.48 | 22.53 | 24.76 | 15.56 | 5.62 | 9.61 | 1.97 | 5.38 | 4.11 | -18.32 | -17.70 | -10.46 |
OPM % | 23.76% | 18.83% | 21.93% | 25.22% | 24.74% | 8.36% | 14.50% | 3.18% | 9.48% | 6.92% | -34.96% | -898.48% | |
6.77 | 3.06 | 3.45 | 1.06 | 0.79 | 7.64 | 0.99 | 8.64 | 6.50 | 6.86 | 30.12 | 42.81 | 40.89 | |
Interest | 9.78 | 10.58 | 11.19 | 12.03 | 7.87 | 5.94 | 5.20 | 6.15 | 6.83 | 5.49 | 2.94 | 10.90 | 16.78 |
Depreciation | 12.90 | 12.33 | 11.87 | 13.55 | 6.70 | 5.12 | 4.31 | 3.76 | 4.38 | 3.63 | 3.61 | 2.84 | 2.67 |
Profit before tax | 18.10 | 1.63 | 2.92 | 0.24 | 1.78 | 2.20 | 1.09 | 0.70 | 0.67 | 1.85 | 5.25 | 11.37 | 10.98 |
Tax % | 3.37% | 28.83% | 8.22% | -208.33% | 26.40% | -23.64% | -55.05% | 52.86% | -5.97% | 0.00% | 11.81% | 0.00% | |
17.49 | 1.17 | 2.68 | 0.74 | 1.30 | 2.72 | 1.69 | 0.33 | 0.71 | 1.85 | 4.62 | 8.83 | -2.10 | |
EPS in Rs | 2.37 | 0.16 | 0.36 | 0.10 | 0.18 | 0.37 | 0.23 | 0.04 | 0.10 | 0.25 | 0.63 | 1.20 | -0.28 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -33% |
5 Years: | -51% |
3 Years: | -67% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | 21% |
5 Years: | 36% |
3 Years: | 123% |
TTM: | -152% |
Stock Price CAGR | |
---|---|
10 Years: | 30% |
5 Years: | 70% |
3 Years: | 109% |
1 Year: | 122% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 | 73.77 | 73.77 | 73.77 |
Reserves | 169.92 | 169.58 | 166.31 | 125.57 | 83.59 | 87.38 | 91.01 | 93.05 | 96.10 | 97.38 | 110.73 | 119.56 | 119.75 |
99.78 | 107.58 | 92.05 | 93.64 | 98.11 | 45.98 | 47.05 | 40.82 | 40.15 | 34.45 | 29.03 | 145.80 | 148.02 | |
21.59 | 38.82 | 48.67 | 48.77 | 55.95 | 95.52 | 114.50 | 143.60 | 150.74 | 141.23 | 72.62 | 37.67 | 38.31 | |
Total Liabilities | 335.56 | 360.25 | 351.30 | 312.25 | 281.92 | 273.15 | 296.83 | 321.74 | 331.26 | 317.33 | 286.15 | 376.80 | 379.85 |
215.84 | 209.17 | 204.71 | 192.54 | 193.73 | 186.87 | 141.09 | 207.73 | 242.75 | 247.98 | 204.11 | 179.19 | 178.02 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 57.61 | 30.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 12.12 | 12.12 | 12.12 | 12.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.81 | 126.34 |
107.60 | 138.96 | 134.47 | 107.59 | 88.19 | 86.28 | 98.13 | 83.20 | 88.51 | 69.35 | 82.04 | 64.80 | 75.49 | |
Total Assets | 335.56 | 360.25 | 351.30 | 312.25 | 281.92 | 273.15 | 296.83 | 321.74 | 331.26 | 317.33 | 286.15 | 376.80 | 379.85 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
70.55 | -1.49 | 27.99 | -14.50 | 16.37 | 44.94 | 15.69 | 51.28 | 17.43 | 19.86 | 16.47 | 12.68 | |
-28.05 | -5.58 | -7.18 | -1.34 | -11.66 | 9.14 | -11.81 | -37.96 | -6.30 | -3.29 | -10.05 | -130.81 | |
-42.03 | 18.11 | -30.11 | 9.40 | -3.33 | -58.05 | -3.82 | -11.35 | -7.88 | -15.63 | 22.05 | 85.17 | |
Net Cash Flow | 0.47 | 11.04 | -9.30 | -6.44 | 1.38 | -3.98 | 0.06 | 1.97 | 3.25 | 0.93 | 28.48 | -32.96 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 130.68 | 207.62 | 234.94 | 326.30 | 377.30 | 343.16 | 411.00 | 344.94 | 381.73 | 191.35 | 158.19 | 0.00 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 130.68 | 207.62 | 234.94 | 326.30 | 377.30 | 343.16 | 411.00 | 344.94 | 381.73 | 191.35 | 158.19 | 0.00 |
Working Capital Days | 105.71 | 210.85 | 203.39 | 209.47 | 167.96 | -8.85 | -51.17 | -314.21 | -355.61 | -394.06 | -57.26 | 6,395.84 |
ROCE % | 9.31% | 3.84% | 4.52% | 4.33% | 3.96% | 0.40% | 3.49% | 3.80% | 4.18% | 4.12% | 2.45% | 7.72% |
Documents
Announcements
- Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (LODR) Regulations, 2015 16 Apr
- Compliance Certificate As per Regulation 40 (9) And 40 (10) Of The SEBI (LODR) Regulation, 2015 16 Apr
- Board Meeting Outcome for Outcome Of Board Meeting Held On April 12,2024 12 Apr
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 8 Apr
- Clarification And Submission Of Revised Corporate Announcement Of Proceedings Of AGM Of The Company Held On 22.09.2023 Along With Explanation For Delay In Disclosure 8 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
MSL is focused on Pharma, Aerospace and Defense Electronics areas, is in the process of acquiring a few companies, and intend to provide centralized corporate, technology, finance, leadership /management support services to such subsidiaries /associate companies